Previous close | 3.9200 |
Open | 3.8400 |
Bid | 3.7000 x 100 |
Ask | 3.8400 x 100 |
Day's range | 3.7600 - 4.0450 |
52-week range | 3.4400 - 6.2000 |
Volume | |
Avg. volume | 90,944 |
Market cap | 163.264M |
Beta (5Y monthly) | 1.45 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
First Quarter Reveals Revenue Decline and Net Loss, Despite Strong Gross Margin
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0% and 4.92%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
It hasn't been the best quarter for Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders, since the share price has...